The companies have been embroiled in a row about compounded GLP-1 drugs that escalated to a lawsuit last month
The insurers unit that manages drug benefits has noted coverage declines and slower utilization growth compared to prior periods, executives said during an earnings call with Wall Street analysts Thursday
Furthermore, a network meta-analysis examining the effects of GLP-1 RA therapy on body composition reported a greater reduction in lean body mass in the intervention group compared with placebo or active comparators (mean difference = 0.86 kg, 95%CI: 1.30, 0.42)
Instead, some med-spas, telehealth companies, and compounding entities have continued compounding or supplying GLP-1s frequently sourcing active pharmaceutical ingredients, or APIs, from abroad, sometimes via unregulated importers
Indias pharmaceutical landscape may be entering a pivotal moment
Take 1 tablet once a day with water AI-generated from the product information